Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
Plos Pathogens
|
August 29, 2014
Adoptive transfer of EBV specific CD8+ T cell clones can transiently control EBV infection in humanized mice
Olga Antsiferova, Anne Müller, Patrick C Rämer, et al.
The Journal of Clinical Investigation
|
August 30, 2016
Cognate HLA absence in trans diminishes human NK cell education
Vanessa Landtwing, Ana Raykova, Gaetana Pezzino, et al.
JCI Insight
|
September 12, 2024
Epstein-Barr virus infection induces tissue-resident memory T cells in mucosal lymphoid tissues
Daniel Kirchmeier, Yun Deng, Lisa Rieble, et al.
Cancer Immunology, Immunotherapy : CII
|
May 16, 2021
Reduced frequency of cytotoxic CD56<sup>dim</sup> CD16<sup>+</sup> NK cells leads to impaired antibody-dependent degranulation in EBV-positive classical Hodgkin lymphoma
Elena Pánisová, Anna Lünemann, Simone Bürgler, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 24, 2025
MTAP expression by immunohistochemistry: a novel biomarker in non-small cell cancer of the lung
Magdalena M Brune, Luca Roma, Obinna Chijioke, et al.
The Journal of Clinical Investigation
|
February 27, 2014
Interactions between Siglec-7/9 receptors and ligands influence NK cell-dependent tumor immunosurveillance
Camilla Jandus, Kayluz Frias Boligan, Obinna Chijioke, et al.
Cell Reports
|
May 5, 2021
KSHV infection drives poorly cytotoxic CD56-negative natural killer cell differentiation in vivo upon KSHV/EBV dual infection
Nicole Caduff, Donal McHugh, Lisa Rieble, et al.
Haematologica
|
September 11, 2025
IGLV3-21<sup>R110</sup>-directed bispecific antibodies activate T cells and promote killing in a high-risk subset of chronic lymphocytic leukemia
Claudia Fischer, Shih-Shih Chen, Johanna Nimmerfroh, et al.
Cell Reports
|
December 24, 2013
Human natural killer cells prevent infectious mononucleosis features by targeting lytic Epstein-Barr virus infection
Obinna Chijioke, Anne Müller, Regina Feederle, et al.
Nature Communications
|
February 2, 2024
Mutation-specific CAR T cells as precision therapy for IGLV3-21<sup>R110</sup> expressing high-risk chronic lymphocytic leukemia
Florian Märkl, Christoph Schultheiß, Murtaza Ali, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
Plos Pathogens
|
August 29, 2014
Adoptive transfer of EBV specific CD8+ T cell clones can transiently control EBV infection in humanized mice
Olga Antsiferova, Anne Müller, Patrick C Rämer, et al.
The Journal of Clinical Investigation
|
August 30, 2016
Cognate HLA absence in trans diminishes human NK cell education
Vanessa Landtwing, Ana Raykova, Gaetana Pezzino, et al.
JCI Insight
|
September 12, 2024
Epstein-Barr virus infection induces tissue-resident memory T cells in mucosal lymphoid tissues
Daniel Kirchmeier, Yun Deng, Lisa Rieble, et al.
Cancer Immunology, Immunotherapy : CII
|
May 16, 2021
Reduced frequency of cytotoxic CD56<sup>dim</sup> CD16<sup>+</sup> NK cells leads to impaired antibody-dependent degranulation in EBV-positive classical Hodgkin lymphoma
Elena Pánisová, Anna Lünemann, Simone Bürgler, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 24, 2025
MTAP expression by immunohistochemistry: a novel biomarker in non-small cell cancer of the lung
Magdalena M Brune, Luca Roma, Obinna Chijioke, et al.
The Journal of Clinical Investigation
|
February 27, 2014
Interactions between Siglec-7/9 receptors and ligands influence NK cell-dependent tumor immunosurveillance
Camilla Jandus, Kayluz Frias Boligan, Obinna Chijioke, et al.
Cell Reports
|
May 5, 2021
KSHV infection drives poorly cytotoxic CD56-negative natural killer cell differentiation in vivo upon KSHV/EBV dual infection
Nicole Caduff, Donal McHugh, Lisa Rieble, et al.
Haematologica
|
September 11, 2025
IGLV3-21<sup>R110</sup>-directed bispecific antibodies activate T cells and promote killing in a high-risk subset of chronic lymphocytic leukemia
Claudia Fischer, Shih-Shih Chen, Johanna Nimmerfroh, et al.
Cell Reports
|
December 24, 2013
Human natural killer cells prevent infectious mononucleosis features by targeting lytic Epstein-Barr virus infection
Obinna Chijioke, Anne Müller, Regina Feederle, et al.
Nature Communications
|
February 2, 2024
Mutation-specific CAR T cells as precision therapy for IGLV3-21<sup>R110</sup> expressing high-risk chronic lymphocytic leukemia
Florian Märkl, Christoph Schultheiß, Murtaza Ali, et al.
Page
of 5